Analyses for abnormality of cell cycle regulator molecules and their application to diagnosis and therapy in bone and soft tissue tumors

细胞周期调节分子异常分析及其在骨和软组织肿瘤诊断和治疗中的应用

基本信息

项目摘要

We have previously reported several diverse functions of cell cycle regulator molecules. In this research project, more detailed analysis was performed using cultured cells as well as human surgical materials of osteosarcoma in comparison to those of lung carcinomas. And, we clarified the followings.i) Overexpression of cyclin D1 or ccdk4, which cause apoptosis in neuronal cultured cells, also caused apoptosis in osteosarcoma and in other cultured cells (Anticancer Res. 2003, Curr. Medic. Chem. 2003).ii) Furthermore, apoptosis induced by overexpression of cyclin D1/cdk4 was observed in human tumors, such as lung carcinomas (Int. J. Cancer 2004).iii) The protein levels of cyclins/cdks were diversely regulated not only by their expression, but also by degradation system, depending on the histological types. In lung carcinoma, cyclin A is highly expressed in proliferating cells and rapidly degraded. However, cyclin E, specifically in squamous cell carcinoma, is accumulated as kinase-inactive-form without degradation in proteasome system (J. Pathol. 2003).iv) Epidermal growth factor receptor (EGFR) is overexpressed in 7 to 15% of the cases in carcinomas of gastrointestinal tract, and overexpression is predominantly caused by gene amplification (Mod. Pathol. 2004).v) Overexpression of EGFR was observed in 2% of bone and soft tissue sarcomas, and those cases were exclusively associated with gene abnormality, i.e., amplification and polysomy (manuscript submitted).
我们以前已经报道了细胞周期调节剂分子的几种不同功能。在该研究项目中,与肺癌相比,使用培养细胞以及骨肉瘤的人类手术材料进行了更详细的分析。并且,我们阐明了以下内容。作为肺癌(Int。J.Cancer 2004).III)细胞周期蛋白/CDK的蛋白质水平不仅通过其表达,而且由降解系统受到多种调节,具体取决于组织学类型。在肺癌中,细胞周期蛋白A在增殖细胞中高度表达并迅速降解。然而,细胞周期蛋白E,特别是在鳞状细胞癌中,积累为激酶无活性形式而没有蛋白酶体系统中没有降解(J.Pathol。2003).IV)表皮生长因子受体(EGFR)在7至15%的病例中过表达了胃肠道的癌症中的7至15%的胃肠道(模型),并且是由基因表达的。 2004).v)在2%的骨骼和软组织肉瘤中观察到EGFR的过表达,这些病例仅与基因异常有关,即放大和多症(手稿)。

项目成果

期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dobashi, Y., et al.: "Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas."Journal of Pathology. 199(2). 208-220 (2003)
Dobashi, Y. 等人:“人原发性肺癌中 G1/S 细胞周期蛋白的表达多样性及其预后意义。”病理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Dobashi, Y., et al.: "Overexpression of Cdk4/Cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung Carcinomas."International Journal of Cancer. (In press).
Dobashi, Y. 等人:“Cdk4/Cyclin D1 的过度表达,可能是细胞凋亡的介质,也是人原发性肺癌预后的指标。”国际癌症杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Dobashi, Y., et al.: "Overexpression of Cdk4/Cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung Carcinomas."International Journal of Cancer. 110(4). 532-541 (2004)
Dobashi, Y. 等人:“Cdk4/Cyclin D1 的过度表达,可能是细胞凋亡的介质,也是人原发性肺癌预后的指标。”国际癌症杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sakurai, H, Dobashi, Y, Mizutani, E, Matsubara, H., Suzuki, S, Takano, K, Shindo, S, Matsumoto, M.: "Bronchioloalveolar carcinoma of the lung 3 cm or less in diameter : A prognostic assessment."Ann Thorac Surg. (In Press).
Sakurai, H, Dobashi, Y, Mizutani, E, Matsubara, H., Suzuki, S, Takano, K, Shindo, S, Matsumoto, M.:“直径 3 厘米或以下的细支气管肺泡癌:预后评估
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Dobashi, Y, Jiang, SX, Shoji, M, Morinaga, S., Kameya, T.: "Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas."J.Pathol.. 199(2). 208-220 (2003)
Dobashi, Y, Jiang, SX, Shoji, M, Morinaga, S., Kameya, T.:“人原发性肺癌中 G1/S 细胞周期蛋白的表达多样性及其预后意义。”J.Pathol.. 199(2)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOBASHI Yoh其他文献

DOBASHI Yoh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOBASHI Yoh', 18)}}的其他基金

Involvement of Akt/mTOR in lung cancer and design of novel therapy targeting them
Akt/mTOR 与肺癌的关系及其新疗法的设计
  • 批准号:
    26460438
  • 财政年份:
    2014
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aberrant activations of cellular kinases and exploration of novel targeted therapy in human solid cancers
细胞激酶的异常激活和人类实体癌新型靶向治疗的探索
  • 批准号:
    23590409
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Activation of signal transduction pathway by aberration of oncogenes : comprehensive analysis and application for multi-molecular targeting therapy
癌基因畸变激活信号转导通路:多分子靶向治疗的综合分析与应用
  • 批准号:
    20590351
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aberrant activation of signal transduction pathways regulating cell proliieration in human slid tumors. Molecular-pathological analysis and clinical application of molecular targeting therapy.
调节人类肿瘤细胞增殖的信号转导途径的异常激活。
  • 批准号:
    18590327
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of abnomatily of cell cycle regulation and its clinical application in human lung cancer
人肺癌细胞周期调控异常及其临床应用研究
  • 批准号:
    11670191
  • 财政年份:
    1999
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

低氧在启动猪有腔卵泡闭锁过程中对颗粒细胞周期/凋亡的影响及其机制研究
  • 批准号:
    31972564
  • 批准年份:
    2019
  • 资助金额:
    57 万元
  • 项目类别:
    面上项目
HASEP短肽在肝癌细胞增殖和凋亡中的作用及其功能网络
  • 批准号:
    81872259
  • 批准年份:
    2018
  • 资助金额:
    53.0 万元
  • 项目类别:
    面上项目
糖尿病白内障中Mcl-1调控线粒体凋亡及G2/M周期阻滞的分子机制及功能研究
  • 批准号:
    81873677
  • 批准年份:
    2018
  • 资助金额:
    53.0 万元
  • 项目类别:
    面上项目
肾小管再生过程中细胞启动增殖的关键机制研究
  • 批准号:
    81800596
  • 批准年份:
    2018
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mechanisms of Parp inhibitor-induced bone marrow toxicities
Parp 抑制剂诱导骨髓毒性的机制
  • 批准号:
    10637962
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
  • 批准号:
    10679988
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Investigating hematopoietic stem cell dysfunction during sickle cell disease
研究镰状细胞病期间的造血干细胞功能障碍
  • 批准号:
    10681829
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
  • 批准号:
    10666307
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Human brain multi-omics to decipher major depression pathophysiology
人脑多组学破译重度抑郁症病理生理学
  • 批准号:
    10715962
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了